Product Information

ADDERALL XR 30 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $6.8069 per EA under NDC 54092039101. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Oct 11, 2001. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

NDC

54092039101

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021303

FDA Approved

10/11/2001

TE Code

AB1

On Market Since

10/11/2001

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for ADDERALL XR 30 MG CAPSULE has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 2.1%. The table below summarizes its recorded NADAC range and movement.

Current price$6.8069 per EA
All-time high$6.9503 (Jul 16, 2014)
All-time low$6.8069 (Nov 18, 2026)
52-week high$6.8116
52-week low$6.8069
Median price$6.8431
Average price$6.8563
Largest weekly change-0.7% (Jan 18, 2017)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-0.0%

1M

-0.0%

3M

-0.0%

6M

-0.0%

1Y

-0.1%

3Y

-0.4%

5Y

-0.6%

All

-2.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 92%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ADDERALL XR 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ADDERALL XR 30 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $6.8069 per EA (NDC 54092039101), effective Nov 18, 2026.

How has the price of ADDERALL XR 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ADDERALL XR 30 MG CAPSULE has declined 2.1%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ADDERALL XR 30 MG CAPSULE?

Since Nov 28, 2013, the NADAC for ADDERALL XR 30 MG CAPSULE has ranged from a low of $6.8069 (Nov 18, 2026) to a high of $6.9503 (Jul 16, 2014), with a median of $6.8431 per EA.

Are there cheaper alternatives to ADDERALL XR 30 MG CAPSULE?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 30 MG CAP, is $0.5226 per EA — about 92% below ADDERALL XR 30 MG CAPSULE.

Who manufactures ADDERALL XR 30 MG CAPSULE?

ADDERALL XR 30 MG CAPSULE (NDC 54092039101) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.